Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by InterVene, Inc.

InterVene Receives FDA 510(k) Clearance for Recana®, the First Fully Integrated Thrombectomy System for Venous In-Stent Restenosis and Native Vessel Obstructions
From InterVene, Inc.
Via Business Wire
InterVene, Inc. Announces First Patient Treated With the Recana™ Thrombectomy Catheter System
From InterVene, Inc.
Via Business Wire
InterVene, Inc. Announces $13 Million Series A Financing to Advance Recana™ System Through US Market Clearance
From InterVene, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.